ArticleNanomaterials (Basel, Switzerland)2025
Intra-Articular Injection in Wistar Rats: Standardization and Experimental Validation of a Precise Protocol for Nanomaterial Administration.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Rare-Earth Element Microdoping on Ti-6Al-7Nb Alloys for Biomedical Applications: Materials Characterization and In Vivo Biocompatibility Tests.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
(1) Background: Intra-articular injection is a fundamental technique in preclinical research for evaluating therapeutics and inducing joint disease models in rodents. However, the absence of standardized and validated protocols compromises reproducibility and translational validity. (2) Methods: This study establishes and experimentally validates a refined protocol for precise intra-articular injection in the knee of adult male Wistar rats. The comprehensive procedure specifies anatomical landmarks (medial border of the patellar tendon), instrumentation (27 G needle, 100 µL Hamilton syringe), a maximum volume of 35 µL, and operative verification criteria based on tactile feedback. Experimental validation was performed by administering a suspension of wear particles (2.35 mg/mL) generated from tribocorrosion tests of CoCr surfaces biofunctionalized with graphene oxide-hyaluronic acid (GO-HA) into the left knee of five rats. (3) Results: Histological analysis using the cutting-grinding technique and Toluidine Blue staining confirmed the exclusive intra-articular localization of particles in all injected animals (5/5 success rate). Qualitative assessment revealed abundant particulate distribution within the synovial space, with numerous individual particles and multiple aggregates observed per high-power field, without evidence of extravasation in any case. (4) Conclusions: The protocol demonstrated high intra-operator repeatability and provides a reliable, ethically refined tool for precise intra-articular administration of nanomaterials and for generating robust joint disease models, thereby enhancing reproducibility and animal welfare in preclinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.